Koschmieder Steffen, Miesbach Wolfgang, Fauth Florian, Bojunga Joerg, Scharrer Inge, Brodt Hans-Reinhard
Zentrum für Innere Medizin, Universitätsklinikum, Johann Wolfgang Goethe-Universität, Frankfurt, Germany.
Blood Coagul Fibrinolysis. 2003 Jun;14(4):395-9. doi: 10.1097/00001721-200306000-00011.
We report the case of a 33-year-old female with known primary antiphospholipid syndrome who, despite full-dose oral anticoagulation, presented with myocardial infarction, acute respiratory distress syndrome, purulent bronchitis, and septic shock. Antiphospholipid antibodies and anti-beta2-glycoprotein-1 titres were markedly elevated. The patient was diagnosed with catastrophic antiphospholipid syndrome and treated with unfractionated intravenous heparin. However, she developed thromboembolism of the right foot and skin marmoration of her extremities during heparin therapy, and therefore plasmapheresis, immunoglobulins, cyclophosphamide, and methylprednisone under a broad spectrum of anti-infective therapy were instituted. This treatment led to a rapid decrease of antiphospholipid antibody and anti-beta2-glycoprotein-1 titres, and the patient's condition gradually improved. Upon discharge from the hospital, pulmonary infiltrates had markedly regressed, and she was feeling well. Given the high mortality of catastrophic antiphospholipid syndrome, this report emphasizes the need for rapid diagnosis and effective multimodal treatment in an intensive care unit setting for these patients.
我们报告了一例33岁已知原发性抗磷脂综合征的女性患者,尽管接受了全剂量口服抗凝治疗,但仍出现心肌梗死、急性呼吸窘迫综合征、化脓性支气管炎和感染性休克。抗磷脂抗体和抗β2糖蛋白1滴度显著升高。该患者被诊断为灾难性抗磷脂综合征,并接受了普通静脉肝素治疗。然而,她在肝素治疗期间出现了右脚血栓栓塞和四肢皮肤大理石样斑纹,因此开始进行血浆置换、使用免疫球蛋白、环磷酰胺,并在广谱抗感染治疗的同时使用甲基泼尼松。这种治疗导致抗磷脂抗体和抗β2糖蛋白1滴度迅速下降,患者的病情逐渐好转。出院时,肺部浸润明显消退,她感觉良好。鉴于灾难性抗磷脂综合征的高死亡率,本报告强调了对这些患者在重症监护病房环境中进行快速诊断和有效多模式治疗的必要性。